Merck, MIR2250, TransIT®</SUP>-mRNA

General description
TransIT®-mRNA Transfection Kit is designed to transfect RNA into a broad range of cell types with minimal cellular toxicity. RNA delivery avoids transcriptional regulation effects by directly delivering the RNA to the cytoplasm for expression. The TransIT-mRNA Transfection Kit can be used to deliver a variety of RNA molecules including mRNAs and viral RNAs (2–10 kb). It can be used for multiple applications such as short-term protein expression, viral production and replication studies. TransIT®-mRNA Transfection Kit contains two components, namely: TransIT®-mRNA Reagent and the mRNA Boost Reagent. This kit is compatible with serum; transfection efficiency is optimal when transfections are performed in the presence of serum, with no medium change required.
Features and Benefits
Each Kit is supplied with the TransIT®-mRNA Transfection Reagent and the mRNA Boost ReagentLow Cellular Toxicity – Maintain cell density and reduce experimental biase
High Efficiency Delivery – Achieve RNA delivery in a large population of cells to ensure experimental success
Serum Compatible – Perform transfections in the presence of serum which eliminates the need for a media change and maintains cellular health
Deliver Various Sizes of RNA – Ideal for specialized applications, such as virus production, protein expression and CRISPR genome editing

Other Notes
Biological Source: raw materials that are derived from animals.

Suitable for: CRISPR/Cas genome editing
Stem cell transfection
VRNA transfection
Co-transfection

Legal Information
TransIT is a registered trademark of Mirus Bio